Structural binding of SL0101 to the murine RSK2 N-terminal domain
Biochemical assay · Recombinant murine RSK2 N-terminal kinase domain, residues 45–346 [1]
The SL0101 complex showed a reorganized nucleotide-binding cleft forming a hydrophobic pocket. Comparison with the AMP-PNP-bound structure revealed major N-lobe, hinge and αD-helix rearrangements. The structural endpoint does not establish cellular potency or proteome-wide selectivity.
| Endpoint | Reported result | Reference |
|---|---|---|
| Diffraction/refinement resolution | resolution 1.53 Å | [1] |
| SL0101 binding-pocket architecture | structural observation Reorganized hydrophobic pocket overlapping the nucleotide-binding site | [1] |
Literature-Reported Treatment Conditions
- Method
- Co-crystallization of the isolated domain with synthesized SL0101; AMP-PNP-bound structure used for comparison.
- Reported limits
- This is a structural study; no treatment dose or IC50 is assigned.
Methods and source locations
Compound reported in the paper: SL0101
Evidence concerns the reported SL0101 material; no Adooq lot, purity or supplier equivalence validation is implied.
Figure 1; Experimental Procedures: Inhibitors and Crystallization and Structure Determination; Table 1; Results Overview and binding-mode section; Figures 3 and 6
Diffraction/refinement resolution: X-ray crystallography; one native crystal per dataset; Rwork/Rfree 0.19/0.22. — Table 1, RSK2-SL0101 column and footnotes
SL0101 binding-pocket architecture: Comparison with AMP-PNP-bound domain; ligand omit electron-density map in Figure 6A. — Figures 3 and 6; Results: binding mode